Delivery Order SPE2DR25D9104-SPE2DR26FRAN9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in an unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The contract, awarded on December 17, 2025, with an ultimate completion date of January 9, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,340.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by November 28, 2025, and was awarded on November 5, 2025. DMS Pharmaceutical Group serves as the prime...
- The Defense Logistics Agency (DLA) awarded a $13,919 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, indicating the vendor competed against other contractors in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,888.62 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The contract is a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of January 13, 2026. This award was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in 1-dose vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and was awarded on November 18, 2025, with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on December 8, 2025, with an ultimate completion date of December 30, 2025, under a firm fixed-price delivery order contract with no set-aside designation. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a $11,135.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The contract, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order falls under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in 1-dose vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $3,147.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The contract, issued on December 22, 2025, with an ultimate completion date of January 14, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- SPE2DR25D9104Indefinite Delivery Contract
- SPE2DR25D9104-SPE2DR26FRAN9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The contract was awarded on December 29, 2025, with an ultimate completion date of January 21, 2026, and utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc. will perform this work at its Park Ridge, Illinois facility. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a critical component of the DLA's $30.3 billion pharmaceutical supply strategy and positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to support Department of Defense military healthcare facilities worldwide. The company's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/28/25 |